Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy

Pembrolizumab is a humanized monoclonal antibody that blocks the programmed cell death 1 (PD-1) pathway, thereby enhancing antitumor immunity. As the use of immune checkpoint inhibitors becomes more prevalent, so do immune-related adverse events associated with their use. The immune-related adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Manam, Rupesh, Martin, Jasmine L, Gross, Joshua A, Chaudhary, Dhishna, Chowdhary, Sajeel, Espinosa, Patricio S, Santos, Edgardo S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257738/
https://www.ncbi.nlm.nih.gov/pubmed/30510881
http://dx.doi.org/10.7759/cureus.3371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257738/
https://www.ncbi.nlm.nih.gov/pubmed/30510881
http://dx.doi.org/10.7759/cureus.3371

Ejemplares similares